The researchers have manipulated the body's own defense against tumors with the so-called gene scissors Crispr-Cas9, and in this way managed to teach a T-cell to attack most cancers without relying on healthy cells.

Angelica Loskog, professor of immunotherapy at Uppsala University, thinks the British study is exciting, but she believes it needs further testing to ensure that no healthy cells are attacked.

Need to be tested on humans

"There are hundreds of different cell types in the body, so some things you just have to test on people in the end," she tells SVT News.

According to Angelica Loskog, it is long before the war on cancer is won but she is optimistic.

- We have lots of different therapies going on and I believe in combinations. We're starting to have so many players that we can start combining them and that's when it gets really interesting.

See how the new method works in the clip above.